No high quality studies on reducing MRSA infection in nursing homes for elderly people

Nursing homes for older people provide environments where bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) are likely to thrive.

Despite this, there are no high quality studies that look specifically at means of reducing the risk of transmission and infection in this setting.

MRSA is a bacterial strain that causes significant disease partly because it is resistant to most commonly used antibiotics. It is most frequently found in communities where antibiotics are frequently taken and where people live close together. In homes for elderly people this is even more problematic in that some residents have pressure sores that are particularly vulnerable to infection.

Given the anxiety about MRSA and the high risk associated with these homes, a team of Cochrane Researchers set out to find studies that aimed to reduce the risk of infection. Having searched the international literature they discovered that there were no studies that met their criteria.

“The lack of studies in this field is surprising,” says lead author Professor Carmel Hughes who works in the School of Pharmacy at Queen's University, Belfast.

“We are aware of one randomised controlled study that is currently underway in nursing homes, however given the importance of the issue we need many more. It is important that we recognise that these homes are very different from hospitals and that we do not simply try to apply findings from research conducted in hospitals,” says Hughes.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Foundation receives $100,000 to advance MS care